Effect of i.c.v. infusion of the α-MSH agonist MTII on meal patterns in male rats following nicotine withdrawal

Life Sciences

Volumn 73, Issue 14, 2003, Pages 1861-1872

  Bellinger, Larry ^a   Cepeda Benito, Antonio ^b   Bullard, Richard L ^a   Wellman, Paul J ^b  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Meal number; Meal size; Melanocortin 3 4 receptors

Indexed keywords

ALPHA INTERMEDIN; ALPHA INTERMEDIN AGONIST; ANOREXIGENIC AGENT; NICOTINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN VENTRICLE; CANNULATION; CEREBROSPINAL FLUID; COMPUTER; CONTROLLED STUDY; DARKNESS; DRUG INFUSION; FOOD INTAKE; MALE; MEAL; MONITOR; NEUROMODULATION; NONHUMAN; PARAMETER; RAT; SMOKING CESSATION;

EID: 0042346448     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00485-5     Document Type: Article

References (37)

1. Bellinger L.L., Bernardis L.L. The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies. Physiology and Behavior. 76:2002;431-442.
2. Bellinger L.L., Castonguay T.W., Bernardis L.L. Hormone and somatic changes in rats pair-fed to growth retarded dorsomedial hypothalamic nuclei-lesioned rats. Brain Research Bulletin. 34:1994;117-124.
3. Bellinger L.L., Cepeda-Benito A., Wellman P.J. Meal patterns in male rats during and after intermittent nicotine administration. Pharmacology Biochemistry and Behavior. 74:2003;495-504.
4. Bellinger L.L., Fabia R., Husberg B.S. Meal patterns prior to and following liver transplantation in rats. Physiology and Behavior. 62:1997;525-529.
5. Bellinger L.L., Mendel V.E. Blood profile and balance study of rats given the putative anorectic agent satietin. American Journal of Physiology. 268:1995;R1-R7.
6. Bellinger L.L., Tillberg C. Third ventricular cannulations, injections, and constant infusions using Alzet pumps in rats. Wellman P.J., Hoebel B. Ingestive Behavior Protocols. 1997;135-148 SSIB, New York.
7. Bishop C., Parker G.C., Coscina D.V. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats. Psychopharmacology. 162:2002;265-272.
8. Blaha V., Yang Z.J., Meguid M., Chai J.K., Zadak Z. Systemic nicotine administration suppresses food intake via reduced meal sizes in both male and female rats. Acta Medica (Hradec Kralove). 4:1998;167-173.
9. Castonguay T.W., Kaiser L.L., Stern J.S. Meal pattern analysis: artifacts, assumptions, and implications. Brain Research Bulletin. 7:1986;439-443.
10. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
11. Frankish H.M., Dryden S., Wang Q., Bing C., MacFarlane I.A., Williams G. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Research. 694:1995;139-146.
12. Grunberg N.E., Bowen D.J., Winders S.E. Effects of nicotine on body weight and food consumption in female rats. Psychopharmacology. 90:1986;101-105.
13. Grunberg N.E., Popp K.A., Bowen D.J., Nespor S.M., Winders S.E., Eury S.E. Effect of chronic nicotine administration on insulin, glucose, epinephrine and norepinephrine. Life Sciences. 42:1988;161-170.
14. Grunberg N.E., Winders S.E., Popp K.A. Sex differences in nicotine's effects on consummatory behavior and body weight in rats. Psychopharmacology. 91:1987;221-225.
15. Hamilton B.S., Doods H.N. Chronic application of MTII in a rat model of obesity results in sustained weight loss. Obesity Research. 10:2002;182-187.
16. Hofstetter A., Schutz Y., Jequier E., Wahren J. Increased 24-hour energy expenditure in cigarette smokers. New England Journal of Medicine. 314:1986;79-82.
17. Kane J.K., Parker S.L., Li M.D. Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat. Neuroscience Letters. 298:2001;1-4.
18. Kane J.K., Parker S.L., Matta S.G., Fu Y., Sharp B.M., Li M.D. Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology. 141:2000;3623-3629.
19. Kirk R.J. Experimental Design. 1982;Wadsworth, Belmont, CA.
20. Levin E.D., Briggs S.J., Christopher N.C., Rose J.E. Sertraline attenuates hyperphagia in rats following nicotine withdrawal. Pharmacology Biochemistry and Behavior. 44:1993;51-61.
21. Levin E.D., Morgan M.M., Galvez C., Ellsion G.D. Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats. Physiology and Behavior. 39:1987;441-444.
22. Li M.D., Kane J.K., Parker S.L., McAllen K., Matta S.G., Sharp B.M. Nicotine administration enhances NPY expression in the rat hypothalamus. Brain Research. 867:2000;157-164.
23. Li M.D., Parker S.L., Kane J.K. Regulation of feeding-associated peptides and receptors by nicotine. Molecular Neurobiology. 22:2000;143-165.
24. Lupien J.R., Bray G.A. Nicotine increases thermogenesis in brown adipose tissue in rats. Pharmacology Biochemistry and Behavior. 29:1988;33-37.
25. Marr K., Wellman P.J., Bellinger L.L. Effects of i.c.v. infusions of neuropeptide-Y (NPY) and cocaine-amphetamine-regulated-transcript (CART) on meal patterns in nicotine (N) treated rats. Experimental Biology. 2003;. (Abstract, CD ROM).
26. Moran T.H., Lee P., Ladenheim E.E., Schwartz G.J. Responsivity to NPY and melanocortins in obese OLETF rats lacking CCK-A receptors. Physiology and Behavior. 75:2002;397-402.
27. Miyata G., Mequid M.M., Fetissov S.O., Torelli M.D., Kim H.-J. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery. 126:1999;255-266.
28. Miyata G., Mequid M.M., Varma M., Fetissov S.O., Kim H.-J. Nicotine alters the usual reciprocity between meal size and meal number in female rats. Physiology and Behavior. 74:2001;169-176.
29. Murphy B., Nunes C.N., Ronan J.J., Hanaway M., Fairhurst A.M., Mellin T.N. Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. Journal of Applied Physiology. 89:2000;273-282.
30. Murrin L.C., Ferrer J.R. Nicotine administration to rats: methodological considerations. Life Sciences. 40:1987;1699-1708.
31. Perkins K.A. Metabolic effects of cigarette smoking. Journal of Applied Physiology. 72:1992;401-409.
32. Rasmussen D.D. Effects of chronic nicotine treatment and withdrawal on hypothalamic proopiomelanocortin gene expression and neuroendocrine regulation. Psychoneuroendocrinology. 23:1998;245-259.
33. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
34. Schwid S.R., Hirvonen M.D., Keesey R.E. Nicotine effects on body weight: a regulatory perspective. American Journal of Clinical Nutrition. 55:1992;878-884.
35. Williams G., Bing C., Cai X.J., Harrold J.A., King P.J., Liu X.H. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiology and Behavior. 74:2001;683-701.
36. Williams D.L., Grill H.J., Weiss S.M., Baird J.P., Kaplan J.M. Behavioral processes underlying the intake suppressive effects of melanocortin 3/4 receptor activation in the rat. Psychopharmacology. 161:2002;47-53.
37. Wirth M.M., Olszewski P.K., Yu C., Levine A.S., Giraudo S.Q. Paraventricular hypothalamic α-melanocyte-stimulating hormone and MTII reduce feeding without causing aversive effects. Peptides. 22:2001;129-134.